The prevalence of diabetes screening during office visits remains low in the US, a new study found. The National Ambulatory Medical Care Survey was used to examine a study sample of office visits from 2012‒2015, reviewing the prevalence of screenings and lab services ordered or provided at each patient visit. Researchers found:
- 105,721 office visits were included in the analysis.
- The diabetes screening prevalence increased from 10% in 2012 to 13.4% in 2015, but remained low overall.
- Physicians primarily prescribed lifestyle modifications, including a healthy diet.
- Metformin was the most common antidiabetic medication prescribed to treat prediabetes.
Shealy KM, Wu J, Waites J, Taylor NA, Blair Sarbacker G. Patterns of diabetes screening and prediabetes treatment during office visits in the US. J Am Board Fam Med. 2019;32(2):209-217. doi:10.3122/jabfm.2019.02.180259.
This Week's Must Reads
Must Reads in Diabetes
Testosterone Therapy to Prevent T2D in Men, Diabetes Care; ePub 2019 Mar 18; Yassin, et al
Patterns of Diabetes Screening During Office Visits, J Am Board Fam Med; 2019 Mar-Apr; Shealy, et al
Muscular Strength and Incidence of Type 2 Diabetes, Mayo Clin Proc; ePub 2019 Mar 11; Wang, et al
Insulin Management in Patients with T2D, Lancet; ePub 2019 Feb 22; Bergenstal, et al
Hospitalization Rates in Young-Onset Diabetes, Ann Intern Med; ePub 2019 Jan 15; Ke, Lau, et al